Morgan; Barry

Patent Applications and Registrations

Patent applications and USPTO patent grants for Morgan; Barry.The latest application filed is for "methods for synthesis of encoded libraries".

Company Profile

0.21.25

Morgan; Barry - Franklin MA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Somatostatin antagonists Grant 9,133,262 - Coy , et al. September 15, 2	2015-09-15
Methods for synthesis of encoded libraries Grant 8,598,089 - Morgan , et al. December 3, 2	2013-12-03
Methods for synthesis of encoded libraries Grant 8,410,028 - Morgan , et al. April 2, 2	2013-04-02
Methods For Synthesis Of Encoded Libraries App 20120245040 - Morgan; Barry ; et al.	2012-09-27
Methods For Identifying Compounds Of Interest Using Encoded Libraries App 20120071329 - Morgan; Barry ; et al.	2012-03-22
Methods For Synthesis Of Encoded Libraries App 20110251089 - Morgan; Barry ; et al.	2011-10-13
Methods for identifying compounds of interest using encoded libraries Grant 7,989,395 - Morgan , et al. August 2, 2	2011-08-02
Methods for synthesis of encoded libraries Grant 7,972,992 - Morgan , et al. July 5, 2	2011-07-05
Methods for synthesis of encoded libraries Grant 7,972,994 - Morgan , et al. July 5, 2	2011-07-05
Methods For Synthesis Of Encoded Libraries App 20110136697 - MORGAN; Barry ; et al.	2011-06-09
Methods for synthesis of encoded libraries Grant 7,935,658 - Morgan , et al. May 3, 2	2011-05-03
Product Comprising A Transduction Inhibitor Of Heterotrimeric G Protein Signals Combined With Another Anti-cancer Agent For Therapeutic Use In The Treatment Of Cancer App 20090270341 - PREVOST; Gregoire ; et al.	2009-10-29
Somatostatin Antagonists App 20090253638 - Coy; David H. ; et al.	2009-10-08
Somatostatin antagonists Grant 7,550,423 - Coy , et al. June 23, 2	2009-06-23
Methionine aminopeptidase-2 inhibitors and methods of use thereof App 20090156624 - Olson; Gary L. ; et al.	2009-06-18
Methods for synthesis of encoded libraries App 20090062147 - Morgan; Barry ; et al.	2009-03-05
Therapeutic agents and methods of use thereof for the treatment of melanoma Grant 7,405,194 - Olson , et al. July 29, 2	2008-07-29
Methionine aminopeptidase-2 inhibitors and methods of use thereof Grant 7,348,307 - Olson , et al. March 25, 2	2008-03-25
Methods and compositions for modulating sphingosine -1- phosphate (S1P) receptor activity App 20080064662 - Saha; Ashis K. ; et al.	2008-03-13
Methods for identifying compounds of interest using encoded libraries App 20070224607 - Morgan; Barry ; et al.	2007-09-27
Methionine aminopeptidase-2 inhibitors and methods of use thereof App 20070161570 - Olson; Gary L. ; et al.	2007-07-12
Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity Grant 7,241,812 - Saha , et al. July 10, 2	2007-07-10
Therapeutic agents and methods of use thereof for the modulation of angiogenesis App 20070117758 - Olson; Gary L. ; et al.	2007-05-24
Methods for synthesis of encoded libraries App 20070042401 - Morgan; Barry ; et al.	2007-02-22
Methionine aminopeptidase-2 inhibitors and methods of use thereof App 20070010452 - Olson; Gary L. ; et al.	2007-01-11
Therapeutic agents and methods of use thereof for the modulation of angiogenesis Grant 7,157,420 - Olson , et al. January 2, 2	2007-01-02
Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity App 20060223866 - Evindar; Ghotas ; et al.	2006-10-05
Therapeutic agents and methods of use thereof for the modulation of angiogenesis App 20060223758 - Olson; Gary L. ; et al.	2006-10-05
Methionine aminopeptidase-2 inhibitors and methods of use thereof Grant 7,105,482 - Olson , et al. September 12, 2	2006-09-12
Therapeutic agents and methods of use thereof for the modulation of angiogenesis Grant 7,084,108 - Olson , et al. August 1, 2	2006-08-01
Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity App 20060135786 - Saha; Ashis K. ; et al.	2006-06-22
Product inhibiting transduction of G heterotrimeric protein signals combined with another anti-cancer agent for therapeutic use in cancer treatment Grant 7,034,024 - Prevost , et al. April 25, 2	2006-04-25
Product comprising a transduction inhibitor of heterotrimeric G protein signals combined with another anti-cancer agent for therapeutic use in the treatment of cancer App 20060074078 - Prevost; Gregoire ; et al.	2006-04-06
Methods for synthesis of encoded libraries App 20050158765 - Morgan, Barry ; et al.	2005-07-21
Therapeutic agents and methods of use thereof for the modulation of angiogenesis App 20050130903 - Olson, Gary L. ; et al.	2005-06-16
Methionine aminopeptidase-2 inhibitors and methods of use thereof App 20050059585 - Olson, Gary L. ; et al.	2005-03-17
Somatostatin antagonists App 20040097418 - Coy, David H. ; et al.	2004-05-20
Somatostatin antagonists Grant 6,703,481 - Coy , et al. March 9, 2	2004-03-09
Transcription factor modulators and uses thereof App 20030224992 - Joyal, John L. ; et al.	2003-12-04
Therapeutic agents and methods of use thereof for the modulation of angiogenesis App 20030109671 - Olson, Gary L. ; et al.	2003-06-12
Therapeutic agents and methods of use thereof for the modulation of angiogenesis App 20020151493 - Olson, Gary L. ; et al.	2002-10-17
Somatostatin antagonists Grant 6,262,229 - Coy , et al. July 17, 2	2001-07-17
Inhibition of H. pylori proliferation Grant 5,968,903 - Kaneko , et al. October 19, 1	1999-10-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.